/Lists

Biotech Investors & VC Firms in Japan

156 firms in this list, with a median first check of $400K. 33 of them lead rounds. Generated from verified public data and updated continuously.

HongShan Capital Group
Hong KongSeed–Growth$100K – $50M
89 people
Gobi Partners
Hong KongSeed–Series A
73 people
SBI Investment Korea Co. Ltd.
SeoulSeries A–Series C$200K – $10M
33 people
Antler Australia
SingaporePre-Seed–Growth$260K
63 people
EQT Life Sciences
AmsterdamSeed–Late Stage$11M – $66M
59 people
Eight Roads Ventures
MumbaiSeed–Growth$5M – $30M
33 people
Celesta Capital
San MateoPre-Seed–Series C$5M – $10M
26 people
Basecamp Fund
ManchesterPre-Seed–Late Stage$100K – $10M
15 people
Seventure Partners
ParisSeed–Growth
19 people
Taiwania Capital
TaipeiSeed–Growth
49 people
GoAhead Ventures
Menlo ParkPre-Seed–Seed$1M
12 people
Sozo Ventures
Redwood CityPre-Seed–Late Stage
29 people
SAV (Scale Asia Ventures)
Palo AltoPre-Seed–Growth$100K – $25M
16 people
ARCHIMED Japan
New YorkGrowth$11M – $1.1B
24 people
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$200K – $5M
25 people
Vertex Ventures China
SingaporePre-Seed–Series A
6 people
Samsung Ventures
SeoulSeries A
26 people
Mitsui Global Investment
Menlo ParkSeed–Series A$500K – $10M
15 people
Fortune Venture Capital
ShenzhenSeed–Series C
11 people
Alloy Partners
IndianapolisPre-Seed–Seed
22 people
Pangaea Ventures Us Inc.
VancouverSeed–Series B$500K – $1.5M
15 people
Magna Investment
SeoulSeed–Growth
17 people
2080 Ventures
Pre-Seed–Seed$100K – $500K
19 people
Incubate Fund
MumbaiPre-Seed–Series A
14 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.